Author

Brian Desch

OpenAlex ID: A5116448397

Advanced-2: Phase 2 Open-label Study to Evaluate Safety and Anti-tumor Activity of Intravesical Instillation of Tara-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

2025 · Brian Mazzarella, Gautam Jayram, et al. · Urologic Oncology Seminars and Original Investigations · 2

ADVANCED-2: Interim efficacy and safety data in BCG-unresponsive participants with high-grade non-muscle invasive bladder cancer.

2026 · Raj Satkunasivam, Timothy D. Lyon, et al. · Journal of Clinical Oncology · 1

Ip02-40 Preliminary Anti-tumor Activity and Safety Results From Advanced-2: a Phase 2 Open-label Study of Intravesical Tara-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

2025 · Gautam T. Jayram, Eugene Kramolowsky, et al. · The Journal of Urology · 1

Ip02-04 Advanced-2 (cohort A): Preliminary Efficacy and Safety Data in Bcg-naïve Participants With High-grade Non-muscle Invasive Bladder Cancer

2026 · Mark Tyson, Gautam Jayram, et al. · The Journal of Urology

Ip20-13 Advanced-2 (cohort B): Interim Efficacy and Safety Data in Bcg-unresponsive Participants With High-grade Non-muscle Invasive Bladder Cancer

2026 · Timothy Clinton, Raj Satkunasivam, et al. · The Journal of Urology

Interim safety and tolerability of TARA-002 in patients with BCG-naïve and unresponsive high-grade non-muscle invasive bladder cancer in ADVANCED-2.

2026 · Timothy Clinton, Timothy D. Lyon, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 4

H-index: 1

I10-index: